Concept information
Preferred term
Rituximab
Type
-
Topical Descriptor
Broader concept
Entry terms
- CD20 Antibody, Rituximab
- Rituximab CD20 Antibody
Scope note
- A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
History note
- 2016 (1995)
In other languages
-
Finnish
-
Swedish
-
Mabthera
-
Rituxan
URI
http://www.yso.fi/onto/mesh/D000069283
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}